0.00Open0.00Pre Close0 Volume0 Open Interest119.00Strike Price0.00Turnover156.92%IV-23.37%PremiumNov 22, 2024Expiry Date22.54Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9204Delta0.0109Gamma4.18Leverage Ratio-0.2831Theta-0.0075Rho-3.85Eff Leverage0.0130Vega
Merck & Co Stock Discussion
Most of my stocks were closed out with profits but offset by losses in some underperforming stocks like $Centene (CNC.US)$ , $Nike (NKE.US)$ , $Merck & Co (MRK.US)$ and $Celsius Holdings (CELH.US)$ .
Both $NVIDIA (NVDA.US)$ and $Tesla (TSLA.US)$ are crucial in my portfolio for long term trading.
I had added more positions in Tesla after US election because I believe Te...
loading...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
Gapping up
$Merck & Co (MRK.US)$ shares modestly rose by 0.4% after securing a lucrative deal with LaNova Medicines, aimed at developing and marketing a new cancer treatment, potentially worth $3.3 billion.
$Disney (DIS.US)$ experienced a 9% increase in stock prices after surpassing expected fourth-quarter income and revenue, driven by strong performance in its streaming services, which significantly boosted i...
No comment yet